Hepatitis Therapeutics Market Size, Share | Industry Report 2025

The Global Hepatitis Therapeutic market was valued at $ 23.4 Billion in 2017 and is forecast to grow at a modest 3.6 % CAGR between 2018 and 2025, culminating in 2025 global sales of $ 27.8 Billion. Rising viral infection including type A, B, C, D, E and possible G are major cause of hepatitis. Hepatis B and C can cause chronic hepatitis. Symptoms of acute hepatitis A include fatigue, flu like conditions or dark urine where as chronic hepatitis are mild and non-specific.

As per Center for Disease Control (CDC), in 2017 reported cases of hepatitis C nearly tripled, reaching 15 years high. Actually 10 times more patients get undetected. Similarly, 1,390 new patients reported with Hepatitis A and 3,370 new cases of Hepatitis B in 2015. We are observing steep rise in cases of hepatitis C in particular in last few years and trend is going to continue. Patients with autoimmune disorder are adding to increase prevalence of hepatitis. Aging population and changing societal behavior adding to this steady increase. Globally, in 2015, an estimated 257 million people were living with chronic HBV infection, and 71 million people with chronic HCV infection.

We are observing increasing deaths due to viral hepatitis globally, 1.34 million deaths in 2015, comparable to deaths caused by tuberculosis and higher than those caused by HIV. However, the number of deaths due to viral hepatitis is increasing over time, while mortality caused by tuberculosis and HIV is declining.

We have segmented the market based on medications and vaccines. We will help our client in understanding market segment for individual treatment type if necessary at a premium service.

Click the link below to view the report description:
www.ameriresearch.com/product/global-hepatitis-therapeutics-market-size/

Key findings from the study: -

• We are observing increasing deaths due to viral hepatitis globally, 1.34 million deaths in 2015, comparable to deaths caused by tuberculosis and higher than those caused by HIV. However, the number of deaths due to viral hepatitis is increasing over time, while mortality caused by tuberculosis and HIV is declining.

• We have profiled major players in the market as Sanofi, GSK, Merck & Co., Roche, Bristol-Myers Squibb Company, Gilead, Vertex Pharmaceuticals, Three Rivers Pharma, Schering, Janssen Pharmaceuticals, Schering, Gilead Sciences, Merck Sharp Dohme.

Ameri Research has segmented the Hepatitis Therapeutics Market by material categories, product type, end-use and region:

Market Segmentation:

Global Hepatitis Therapeutics Market by Disease Types (Revenue, USD Million, 2014- 2025)
• Hepatitis A
• Hepatitis B
• Hepatitis C
• Hepatitis D
• Hepatitis E
• Others

Global Hepatitis Therapeutics Market by Products (Revenue, USD Million, 2014 – 2025)
• Medications
• Vaccines

Global Hepatitis Therapeutics Systems Regional Outlook (Revenue, USD Million, 2014- 2025)
• North America
o U.S.
o Canada

• Europe
o UK
o Germany
o France
o Italy
o Spain

• Asia Pacific
o Japan
o China
o India
o Australia

• Latin America
o Brazil
o Mexico
o Columbia

• Middle East and Africa
o South Africa
o Saudi Arabia

Browse Full Report @ www.ameriresearch.com/product/global-hepatitis-therapeutics-market-size/

About Us:

Ameri Research Inc. (www.ameriresearch.com) is a U.S. based market research and consulting company, registered in the State of Florida and headquartered in Tampa Bay Area. At Ameri Research we are passionately curious about people, markets, brands and society. Our ability to gauge market movements, deep expertise in data science, strong domain expertise and years of collective global experiences helps us to bring unmatched quality in deliverables to our clients. With carefully planned systems and processes in place, we cater to the requirements of our clients in a timely and cost-efficient manner, bringing increased predictability to their business. Each year we are publishing more than 100 syndicated reports in healthcare, chemicals, materials, food & beverages, defense & aerospace, media & entertainment, sports & fitness, and energy. We offer our clients a unique depth of knowledge and expertise around-

Market Mapping
Opportunity Assessment
Positioning
Pricing Analysis
Market Entry Strategy
Competitive Intelligence
Program Evaluation
Performance Reporting
Data Analytics
Developing a culture of collaboration and curiosity, we attract the highest caliber of likeminded people having ability to influence and shape the future.

Follow us on LinkedIn for our latest upcoming reports www.linkedin.com/company/ameri-research-inc./
Follow us on Facebook for our latest upcoming reports www.facebook.com/AmeriResearchInc/
Follow us on Twitter for our latest upcoming reports www.twitter.com/AmeriResearch

Contact Us:

Ameri Research Inc.
6816 Muncaster Ct,
Tampa, FL 33625
United States.
Tel: 1-813-666-0858
Email: Inquiry@ameriresearch.com
Web: www.ameriresearch.com

This release was published on openPR.